Overall, 57% of participants had evidence on PET/MRI of inflammation affecting the heart or lungs.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
A study yesterday in Journal of School Choice found that US schools in poor districts with large non-white student populations are less likely to reopen fully for the 2020 to 2021 academic year.
Tuberculosis notifications in the hard-hit countries of India, Indonesia, and the Philippines have fallen 25% to 30% because of pandemic-related disruptions.
In US developments, cases are rising in 36 states, including a large swath of the Midwest and Northeast.
In one of the first large-scale studies of COVID-19 transmission in US childcare programs, no association was found between day care exposure and COVID-19 transmission risk for providers.
Those who consulted government sources held more science-based beliefs about the pandemic.
Both a vaccine trial and monoclonal antibody trial have been paused.
Only 2 of 101 newborns had positive COVID-19 test results, but they had no signs or symptoms.
The first SARS-CoV-2 infections in US animals were confirmed in large cats at the Bronx Zoo in March during the height of the local COVID-19 outbreak. An American Society for Microbiology study today details the genomic characteristics of viruses that infected zookeepers, four tigers, and three African lions, supporting a human-to-animal transmission pathway.
The vast majority of the world is still susceptible to the virus, the WHO director says.
A study late last week found that convalescent plasma (CP) treatment did not significantly reduce mortality, but improved hospital discharge rates for patients 65 and older. The study in Clinical Infectious Diseases is one of the first to analyze clinical outcomes for closely matched cohorts of CP and control patients.
